ID: ALA3753075

Max Phase: Preclinical

Molecular Formula: C27H31ClN4O3S

Molecular Weight: 527.09

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1cc2c(cc1Cl)N(C(=O)Nc1ccc(S(=O)(=O)N(CCN(C)C)Cc3ccccc3)cc1)CC2

Standard InChI:  InChI=1S/C27H31ClN4O3S/c1-20-17-22-13-14-32(26(22)18-25(20)28)27(33)29-23-9-11-24(12-10-23)36(34,35)31(16-15-30(2)3)19-21-7-5-4-6-8-21/h4-12,17-18H,13-16,19H2,1-3H3,(H,29,33)

Standard InChI Key:  GEPAZHSJKGQJML-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 527.09

Molecular Weight (Monoisotopic): 526.1805

AlogP: 5.00

#Rotatable Bonds: 8

Polar Surface Area: 72.96

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 11.15

CX Basic pKa: 7.54

CX LogP: 4.94

CX LogD: 4.56

Aromatic Rings: 3

Heavy Atoms: 36

QED Weighted: 0.45

Np Likeness Score: -1.85

References

1. Éliás O, Nógrádi K, Domány G, Szakács Z, Kóti J, Szántay C, Tarcsay Á, Keserű GM, Gere A, Kiss B, Kurkó D, Kolok S, Némethy Z, Kapui Z, Hellinger É, Vastag M, Sághy K, Kedves R, Gyertyán I..  (2016)  The influence of 5-HT(2A) activity on a 5-HT(2C) specific in vivo assay used for early identification of multiple acting SERT and 5-HT(2C) receptor ligands.,  26  (3): [PMID:26748694] [10.1016/j.bmcl.2015.12.071]

Source

Source(1):

• Scientific Literature